Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance.

@article{Chen2011SunitinibFT,
  title={Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance.},
  author={Yen-Yang Michael Chen and C. -N. Yeh and Chi-Tung Cheng and Tsung-Wen Chen and K A Rau and Yi-yin Jan and M. -F. Chen},
  journal={World journal of gastroenterology},
  year={2011},
  volume={17 16},
  pages={2113-9}
}
AIM To report preliminary results of the efficacy and safety of sunitinib in the management of Taiwanese gastrointestinal stromal tumors (GIST) patients facing imatinib mesylate (IM) intolerance or failure. METHODS Between 2001 and May 2010, 199 Taiwanese patients with metastatic GIST were treated at Chang Gung Memorial Hospital. Among them, 23 (11.6%) patients receiving sunitinib were investigated. RESULTS Sixteen male and 7 female patients with a median age of 59 years (range: 24-83 years… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…